Coherus BioSciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 17th, 2022
Coherus BioSciences (Nasdaq: CHRS) will release its Q4 and full-year 2021 financial results on February 17, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Coherus BioSciences (Nasdaq: CHRS) will release its Q4 and full-year 2021 financial results on February 17, 2022, after market close. A conference call and webcast will follow at 5 p.m. ET to discuss these results and provide a business update. Investors can access the results on Coherus' website following the announcement. Interested parties are advised to dial in 15 minutes early for the call. The contact for investor relations is Cheston Turbyfill, reachable at IR@coherus.com.
Details
News Market Reaction – CHRS
The recorded move for CHRS in the trading session of this news was +1.74%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its fourth quarter and full year 2021 financial results will be released after market close on Thursday, February 17, 2022. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
After releasing fourth quarter and full year 2021 financial results, the Company will post them on the Coherus website at https://investors.coherus.com.
Conference Call Information
When: Thursday, Feb. 17, 2022, starting at 5 p.m. ET
Dial-in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)
Conference ID: 3677018
Webcast: https://investors.coherus.com/upcoming-events
Please dial-in 15 minutes early to ensure a timely connection to the call.
Coherus Contact Information:
Cheston Turbyfill
Coherus BioSciences, Inc.
IR@coherus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.